MARK CURRAN, PH. D.
HEAD OF DATA SCIENCE
Mark Curran, Ph.D. is Vice President, Head of Data Science for the Immunology Therapeutic Area at Janssen Research & Development, LLC. In this role, Mark is responsible for building an analytical group that will mine for and provide data that can inform and drive clinical trial design and pipeline decision-making. Mark’s work will generate and synthesize data across areas such as target identification, target validation, engineering of therapeutic molecules, and identification of selection and response biomarkers.
Mark joined Janssen in 2008, and was most recently Vice President, Systems Pharmacology and Biomarkers, where he was responsible for incorporating emerging science and human genetics into new programs to create more personalized treatment approaches predictive of response.
Before joining Janssen, Mark was Director of Biomarker Biology at Bristol-Myers Squibb where he worked across multiple therapeutic areas and led Early Development Teams conducting phase 1, 2 and experimental medicine trials for numerous development assets. Prior to that, Mark had roles of increased responsibility at DNA Sciences, ICAgen and Sequana Therapeutics/Axys Pharmaceuticals.
Mark earned a Ph.D. in Human Genetics from the University of Utah and his undergraduate and masters’ degrees from Worcester Polytechnic Institute.